UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers

Breast cancer research and treatment, 2017-08, Vol.164 (3), p.667-678

2017

Link zum Volltext

Verfügbarkeit prüfen

Nuclear osteopontin-c is a prognostic breast cancer marker

British journal of cancer, 2015-02, Vol.112 (4), p.729-738

2015

Link zum Volltext

Verfügbarkeit prüfen

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

Histopathology, 2007-10, Vol.51 (4), p.491-498

2007

Link zum Volltext

Verfügbarkeit prüfen

P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

HemaSphere, 2022-06, Vol.6, p.280-281

2022

Link zum Volltext

Verfügbarkeit prüfen

Experience in treatment of metastatic pulmonary carcinoid tumors

Annals of oncology, 2001-10, Vol.12 (10), p.1383-1391

2001

Link zum Volltext

Verfügbarkeit prüfen

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides

British journal of cancer, 2006-06, Vol.94 (11), p.1697-1702

2006

Link zum Volltext

Verfügbarkeit prüfen

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort

International journal of cancer, 2010-08, Vol.127 (4), p.961-967

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs

Medical oncology (Northwood, London, England), 2002, Vol.19 (1), p.35-42

2002

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel-induced cytotoxicity—the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein

European journal of cancer (1990), 1994, Vol.30 (5), p.687-690

1994

Link zum Volltext

Verfügbarkeit prüfen

Lack of relationship between systemic exposure for the component drugs of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1581-1588

1996

Link zum Volltext

Verfügbarkeit prüfen

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

Cancer, 2001-09, Vol.92 (5), p.1101-1107

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-02-02: Cyclin D1 overexpression increases the risk for breast cancer death 4-fold in hormone receptor positive and node negative breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-02-02

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-17-01: Whole genome methylation patterns in male and female breast cancer – Unexpected findings

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-17-01

2013

Link zum Volltext

Verfügbarkeit prüfen

Is Cremophor EL, solvent for paclitaxel, cytotoxic?

The Lancet (British edition), 1993-10, Vol.342 (8875), p.873-873

1993

Link zum Volltext

Verfügbarkeit prüfen

P4-19-06: Ghrelin Expression Is Associated with Favorable Outcome in Male Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-19-06

2011

Link zum Volltext

Verfügbarkeit prüfen

Overview on Human Breast Cancer with Focus on Prognostic and Predictive Factors with Special Attention on the Tumour Suppressor Gene P53

Acta oncologica, 1996, Vol.35 (S5), p.96-102

1996

Link zum Volltext

Verfügbarkeit prüfen

P4-10-01: Tumor Markers Predicting Recurrence Type after a Primary Ductal Carcinoma In Situ

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-10-01

2011

Link zum Volltext

Verfügbarkeit prüfen

P4-19-04: Evaluation of Histopathological Parameters in Male Breast Cancer Reveals Differences Compared with Female Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-19-04

2011

Link zum Volltext

Verfügbarkeit prüfen

P3-07-22: Combined Approach for Staging the Axilla in Breast Cancer Patients with Clinically (−)Nodes Versus Sentinel Node Biopsy Alone

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-07-22

2011

Link zum Volltext

Verfügbarkeit prüfen

Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences

Scandinavian journal of pain, 2018-10, Vol.18 (4), p.581-591

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-10-28

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-16-01: High-Resolution Genomic Profiling of Male Breast Cancer Reveals Differences behind the Similarities with Female Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P1-P1-16-01

2010

Link zum Volltext

Verfügbarkeit prüfen

Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort

32nd Annual San Antonio Breast Cancer Symposium,San Antonio, TX, United States,2009-12-09 - 2009-12-13, 2009, Vol.69 (24_Supplement), p.6051-6051

2009

Link zum Volltext

Verfügbarkeit prüfen

Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1581-1588

1996

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer

Cancer Research, 2014, Vol.72 (24 Supplement)

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(34)
Tagungsberichte
(4)

Sprache

Englisch
(38)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers

Nuclear osteopontin-c is a prognostic breast cancer marker

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

Experience in treatment of metastatic pulmonary carcinoid tumors

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs

Paclitaxel-induced cytotoxicity—the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein

Lack of relationship between systemic exposure for the component drugs of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

Abstract P3-02-02: Cyclin D1 overexpression increases the risk for breast cancer death 4-fold in hormone receptor positive and node negative breast cancer

Abstract P1-17-01: Whole genome methylation patterns in male and female breast cancer – Unexpected findings

Is Cremophor EL, solvent for paclitaxel, cytotoxic?

P4-19-06: Ghrelin Expression Is Associated with Favorable Outcome in Male Breast Cancer

Overview on Human Breast Cancer with Focus on Prognostic and Predictive Factors with Special Attention on the Tumour Suppressor Gene P53

P4-10-01: Tumor Markers Predicting Recurrence Type after a Primary Ductal Carcinoma In Situ

P4-19-04: Evaluation of Histopathological Parameters in Male Breast Cancer Reveals Differences Compared with Female Breast Cancer

P3-07-22: Combined Approach for Staging the Axilla in Breast Cancer Patients with Clinically (−)Nodes Versus Sentinel Node Biopsy Alone

Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain experiences

Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer

Abstract P1-16-01: High-Resolution Genomic Profiling of Male Breast Cancer Reveals Differences behind the Similarities with Female Breast Cancer

Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort

Lack of relationship between systemic exposure for the component drug of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients

Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer

Suchergebnisse filtern